Most clinicians recommend stopping the medication 2-3 months before you intend to try conceiving, giving your body time to eliminate the drug and for metabolic patterns to stabilize
As obesity prevalence has increased, so has the severity of obesity-related complications (ORCs), including cardiometabolic conditions [3]
You've probably heard of the semaglutide brand names Ozempic, Wegovy, and Rybelsus
Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes (SURPASS-2) New England Journal of Medicine Head-to-head comparison showed tirzepatide 15 mg reduced HbA1c by 2.46% vs semaglutide 1 mg 1.86%, with body weight reductions of 12.4 kg vs 6.2 kg at 40 weeks in 1,879 T2D patients
IMP accountability rules mean that participants may not be permitted to carry additional supplies beyond what is authorised by the trial team
On the other hand, patients are advised not to take the medications while pregnant or trying to conceive because animal studies suggest the drugs may raise risks for low birth weights and birth defects